Noetic invests globally to build emerging technologies in molecular therapeutics/biotech, digital health, medical devices, and wellness with a focus on mental health, pain, and other complications resulting from the central nervous system.
“From the Greek noēsis/ noētikos meaning inner wisdom, direct knowing, or subjective understanding”
Noetic science refers to a multidisciplinary field that brings objective scientific tools and techniques together with subjective understanding to study the full range of human experience.
Our mission is to nurture the scientific advancement of mental, emotional, and physiological health by investing in emerging therapies, modalities, and sciences that are committed to optimizing our human experience.
We are committed to developing sustainable therapies, products, and services that are innovative, safe, and accessible to create a better mental health landscape for current and future generations.
CNS-targetted therapeutics and related sustainable solutions for mental health and physical well being.
Noetic Funds focus on finding teams with the skills, expertise, management experience, and governance structures in place to build world class companies. Below is a selection of companies we have invested in.
Eve Health Systems
GHP Noetic Science-Psychedelic Pharma Inc.
Noetic Consciousness Inc
Alexander Shulgin Research Institute
Our Company and Team
Meet The Team
9 years at RBC Capital Markets in real estate banking, corporate credit, and derivative sales & trading
9 years at DGAM (acquired by The Carlyle Group) – Head of Marketing and Client Services, helped build AUM to $6.8B at peak
BA in Economics and Political Science from Columbia University.
9 years at Northwater Capital Management, as Managing Director – Head of Hedge Fund Investments
12 years at DGAM (acquired by The Carlyle Group) as Chief Investment Officer
Partner at The Carlyle Group and Chief Investment Officer of The Carlyle Liquid Markets Group.
COO & CFO
25+ years in the onshore and offshore investment industry
10 years as CFO with a Bermuda-based hedge fund and a Canadian real estate development company
8.5 years at Northwater Capital Management, as VP of Finance & Risk Mgmt. and Hedge Fund Investment Due Diligence
CPA,CA (Canada) and CPA(IL) (U.S.A.)
Chief Technology Officer
Led numerous complex enterprise projects across multiple sectors including government, legal, medical, private and public companies over the past 20+ years
Held C-Level roles in private and public companies
Developed and deployed Clinically Proven technology for Hospitals and Patients in Canada
Robust Data Security experience and numerous certifications
Top 40 under 40 in Ottawa
Richard Cheung, B.Sc.Phm., Ph.D., LL.B.
15+ years advising clients ranging from start-ups to multinational corporations on intellectual property and regulated health products at firms including Fasken, Ogilvy Renault, and Bereskin & Parr
Licensed pharmacist in the Province of Ontario with experience in community and hospital pharmacy
LL.B. from Western University
Ph.D. in Pharmaceutical Sciences and B.Sc.Phm. (Pharmacy) from the University of Toronto
Registered Patent Agent and Trademark Agent in Canada
CCO & Head of Operations
20+ years at Maple Financial Group Inc., serving in a variety of senior finance, compliance and administrative functions
2 years as CFO and CCO at Clearpool Execution Services Canada. Started IIROC-regulated broker-dealer from the beginning. (Company was purchased by BMO in 2020)
Professional designations: CPA, CMA (Canada) and CFA
Principal, Business Development USA
8 years of experience across M&A, innovation, consumer insights, and product development roles in the consumer-packaged goods sector
Co-developed the investment thesis and strategic framework to screen potential CPG acquisitions and investments at Lindsay Goldberg
5 years of training and class facilitation in leadership development at Yale School of Management
MBA from Yale School of Management
BA from Hamilton College
Sri Teja Mullapudi, PhD
Principal, Fund Investments, Scientific Lead
Helped raise and deploy $60M+ in the psychedelic and neuroscience sectors to improve mental healthcare
Experienced in life sciences investment opportunity analyses from TIAP (MaRS Innovation)
8+ years of research experience with 8 publications in peer-reviewed journals
Ph.D. (summa cum laude) in Biology from the Max Planck Society, Germany
M.Tech + B.Tech in Biotechnology (Minor in Chemistry) from Indian Institute of Technology Madras, India
Soccer player with TSV Rödgen, Germany (2014-18), Toronto City FC, Canada (2019-21)
Senior Associate, Administration & Accounting
3+ years of experience in business operations and office administration.
Managed financial accounting for multimillion dollar corporations, including companies operating in medical and pharmaceutical industries.
BA in Economics and Mathematics from the University of British Columbia, with one year study at the National University of Singapore, focusing on financial markets and macroeconomics
Senior Venture Partner
Andy is a 25+ year experienced venture capital and growth investor, CEO and company director with significant international experience.
He has wide experience and interests as an operator/investor and board level advisor at every stage of company lifecycle across the capital structure. He has experience with all transaction types public and private.
Andy is based in London, working closely with the Noetic senior team on strategic issues, most notably fund raising and strategic growth.
Matthew Baggott, PhD
CEO of Tactogen
30-year career spanning data science, preclinical pharmacology, clinical research, neuroscience, genomics and drug development
Bachelor’s degree in Philosophy and Post-doctoral Fellow at the University of Chicago
Ph.D. in Neuroscience from the University of California, Berkeley.
Jeffrey Becker, MD
CSO & Co-Founder of Bexson Biomedical, Inc.
Board-certified in Psychiatry and Integrative & Holistic Medicine
Leader in applied genetics and functional nutrient science in mental health
Ketamine assisted psychotherapy trainer and opinion leader
UC Berkeley Bachelor’s in Biology, Entomology & Religious Mysticism; UCLA Medical graduate & psychiatric resident
David Rabin, MD, PhD
CIO of Apollo Neuroscience
Board-certified psychiatrist, neuroscientist, tech entrepreneur & inventor
Operates a clinical psychiatry practice and conducting research on the epigenetic regulation of trauma responses and recovery
Graduate degrees from Albany Medical College and psychiatric residency from Pittsburgh Medical Center.
Prof. Ede Frecska, PhD
Chairman of Psychiatry at the Faculty of Medicine of the University of Debrecen
Residency training in Psychiatry both in Hungary (1986), and in the United States (1992)
Qualified psychopharmacologist (1987) of international merit
17 years of clinical and research experience in the United States.
25+ years of lifestyle marketing experience with companies including Reebok and Vitaminwater.
8 years developing, executing and implementing national programs which helped define and build the Vitaminwater and Smartwater brands.
Advisory Board member of Cloud Water Brands, Gem&Bolt Mezcal and Prosper Technologies Holdings to name a few.
Adventurer, Explorer, and World Traveler.
9 years at Russell Investments – Head of Italy, helped build AUM to $8B and opened Milan office
6 years as Managing Partner of a single family office investing across all asset classes
6 years in healthcare research and consultancy at Datamonitor and Frost & Sullivan
BA Hon in Business Administration from European Business School in London
Jody Levy is an artist, designer, director, entrepreneur, executive and investor.
Jody is the founder, creative director and Chief Executive Officer of a handful of companies dedicated to empowering people to be as healthy and happy as possible.
Luis Eduardo Luna, PhD
Guggenheim Fellow (1986), Fellow of the Linnaean Society of London (1989), and Doctor Honoris Causa, from St. Lawrence, Canton, New York (2002)
Ph.D. from the Department of Comparative Religion Stockholm University (1989)
Master from Oslo University (1980)
B.A. from Madrid University (1972).
Subscribe to keep in touch and learn about the latest developments in the emerging psychedelic medicine space
Who to Contact
Do you have a question about our Fund?
Please feel free to get in touch by sending us an email to email@example.com.
Do you have a question about your investment?
Please feel free to get in touch by sending us an email to firstname.lastname@example.org.
Do you want the Fund to invest in your company?
Please feel free to get in touch by sending us an email to email@example.com.